Celldex Therapeutics
Utility Patents
Last updated:
List of all Celldex Therapeutics patents 11 in total
| Status | Patent |
|---|---|
Grant | Utility: Antibodies that bind human CD27 and uses thereof Filling date: 9 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Anti-ALK antibodies and methods for use thereof Filling date: 9 Sep 2025 Issue date: 17 Aug 2021 |
Grant | Utility: Methods of inducing or enhancing an immune response comprising administering agonistic anti-CD40 antibodies Filling date: 9 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Nucleic acids encoding agonistic antibodies that bind CD40 Filling date: 9 Sep 2025 Issue date: 15 Dec 2020 |
Grant | Utility: Methods of treating by administering anti-kit antibodies Filling date: 9 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Methods of treating by administering anti-kit antibodies Filling date: 9 Sep 2025 Issue date: 22 Sep 2020 |
Grant | Utility: Treatment of eosinophil or mast cell related disorders Filling date: 9 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: Anti-ErbB antibodies and methods of use thereof Filling date: 9 Sep 2025 Issue date: 18 Aug 2020 |
Grant | Utility: Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment Filling date: 9 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: Agonistic antibodies that bind CD40 Filling date: 9 Sep 2025 Issue date: 28 Apr 2020 |
Grant | Utility: Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment Filling date: 9 Sep 2025 Issue date: 27 Aug 2019 |
Showing 1 to 11 of 11 patents.